HVCN1 Knockout BV2 Cell Line

The choice depends on whether you are studying HVCN1 (Hv1, voltage-gated proton channel 1)'s role as the principal voltage-gated proton channel supporting NADPH oxidase activity or modeling its functions in microglial respiratory burst. The Knockout line is the standard tool for asking whether HVCN1 is required for these processes — HVCN1 is a voltage-gated proton-selective channel that compensates for the electrogenic and pH effects of NADPH oxidase (NOX2) activity, supporting sustained respiratory burst in phagocytes and microglia. Overexpression is useful for studying HVCN1 in heterologous expression contexts. For microglial biology research, the EDITGENE HVCN1 Knockout in BV-2 is uniquely valuable — BV-2 is the most widely used microglial cell line, and HVCN1 is critical for microglial NOX2-driven ROS production implicated in neuroinflammation, ischemic stroke, and neurodegenerative disease. Rescue with wild-type or non-conducting HVCN1 enables structure-function studies. The knockout is a critical specificity tool for HVCN1 inhibitors (5-chloro-2-guanidinobenzimidazole/ClGBI, AbD17561) in development for neuroinflammation and ischemic brain injury — HVCN1 has emerged as a CNS-targeted therapeutic strategy for reducing oxidative damage.

Primary applications: • Voltage-gated proton current: whole-cell patch clamp measurement of voltage-gated H+ currents in HVCN1-null versus rescued microglia. • NADPH oxidase support: NOX2-mediated ROS production (DCF-DA, MitoSOX) following inflammatory stimulation given HVCN1's role in sustaining respiratory burst. • Microglial pH regulation: intracellular pH dynamics during oxidative burst given HVCN1's electrogenic proton extrusion. • HVCN1 inhibitor specificity: critical genetic control for ClGBI (5-chloro-2-guanidinobenzimidazole), AbD17561, and other HVCN1-targeting compounds in neuroinflammation drug development. EDITGENE recommends this microglial model for researchers investigating HVCN1 biology, microglial respiratory burst regulation, and HVCN1-targeted neuroinflammation therapeutics.

Yes. HVCN1 rescue experiments require attention to voltage-gated channel architecture: • Construct design: use a codon-modified HVCN1 sequence with a small intracellular tag (FLAG, HA). HVCN1 has four transmembrane domains (S1-S4) including the voltage-sensing S4 with characteristic positive charges — preserve membrane topology. • Non-conducting rescue: D112A or N214R/D185A pore-related residue mutations abolish H+ conduction and serve as the standard specificity control. • Functional readout: rescue should restore voltage-gated H+ currents measured by patch clamp and NOX2-supported respiratory burst. BV-2-specific considerations: • BV-2 is an immortalized murine microglial cell line (v-raf/v-myc transformed C57BL/6 microglia) — the most widely used continuous microglial cell line for in vitro neuroimmunology research. • Lentiviral transduction is supported with moderate efficiency; characterize basal microglial activation state (M1/M2 markers) before phenotypic assays. • BV-2 retains key microglial markers (CD11b, Iba1, CD68) and TLR/inflammasome responses, but immortalization may alter some primary microglial features — confirm relevant phenotypes in independent assays.